fda bpc-157 compounding category 2 list This just in: The is proposing to move 14 commonly used peptides from to Category 1 on the review π€― If finalized, this shift could significantly change FDA Panel to Review 7
FDA Panel to Review 7 Peptides in July (2026) Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for FDA Removes Peptides from Category 2 List, Paving Way for Regulation Jonathan Cole posted on the topic LinkedIn Is BPC 157 Legal in 2026? FDA Compounding Status Explained FDA Unbans 14 Peptides for Legal US Compounding! : r Biohackers Category 1 vs. Category 2. The FDA's peptide update, explained. Category 2 peptides are on the FDA's difficult to compound list, which effectively blocks licensed pharmacies from producing them. Category 1 means
Pay in 4 interest-free payments of $6.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 6 - Aug 11


